Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial

Published:2005-07-19 Issue:10 Volume:20 Page:2139-2145
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Frisch Gershon,Lin Julie,Rosenstock Jordan,Markowitz Glen,D'Agati Vivette,Radhakrishnan Jai,Preddie Dean,Crew John,Valeri Anthony,Appel Gerald

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/20/10/2139/5450615/gfh974.pdf

Reference22 articles.

1. Donadio J, Grande, J. IgA nephropathy. N Engl J Med2002; 347: 738–748

2. D'Amico G. Natural history of idiopathic IgA nephropathy: the role of clinical and histological prognostic factors. Am J Kidney Dis2002; 36: 227–237

3. Lai K, Lai F, Ho C, Chan K. Corticosteroid therapy in IgAN with nephrotic syndrome: a long term controlled trial. Clin Nephrol1986; 26: 174

4. Cheng IKP, Chan K, Chan M. Mesangial IgAN with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid-induced remission. Am J Kidney Dis1989; 14: 361

5. Pozzi C, Bolasco PG, Locatelli F et al. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet1999; 353: 883–887

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials;Nephrology;2024-07-18

2. Primary IgA Nephropathy: New Insights and Emerging Therapies;Advances in Kidney Disease and Health;2024-05

3. New therapies for immunoglobulin A nephropathy: what's the standard of care in 2023?;Current Opinion in Nephrology & Hypertension;2024-02-23

4. An Update on Current Therapeutic Options in IgA Nephropathy;Journal of Clinical Medicine;2024-02-07

5. Novel Treatment Paradigms: Primary IgA Nephropathy;Kidney International Reports;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3